Table 2.
Compound | 3CLpro | PLpro | ||||||
---|---|---|---|---|---|---|---|---|
Affinity for the best distance mode (kcal/mol) | Mode | Distance His41 (Å) |
Distance Cys145 (Å) |
Distance Glu166 (Å) |
Affinity for the best distance mode (kcal/mol) | Mode | Distance Tyr268 (Å) |
|
1 | − 6.5 | 9 | – | 2.77 | – | − 7.1 | 1 | 2.2 |
2 | − 6.3 | 6 | 2.60 | 2.68 | – | − 5.5 | 7 | 1.9 |
3 | − 7.2 | 3 | – | 3.01 | 2.19 | − 5.7 | 7 | 2.1 |
LPVa | − 5.1 | 9 | 2.92 | – | – | − 5.7 | 9 | 1.8 |
RTVb | − 8.1 | 11 | 2.41 | 2.68 | 2.42 | − 6.9 | 2 | 1.6 |
CLQc | − 6.4 | 1 | – | – | 2.11 | − 5.9 | 8 | 1.1 |
aPositive control: lopinavir
bPositive control: ritonavir
cPositive control: chloroquine